摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-哌啶甲酸甲酯 | 50585-89-2

中文名称
3-哌啶甲酸甲酯
中文别名
甲基哌啶-3-羧酸乙酯;3-哌啶甲酸甲酯或哌啶-3-羧酸甲酯;甲酯哌啶-3-甲酸;(S)-3-哌啶甲酸甲酯;(±)3-哌啶甲酸甲酯
英文名称
3-methoxycarbonylpiperidine
英文别名
methyl piperidine-3-carboxylate;methyl nipecotate;piperidine-3-carboxylic acid methyl ester;nipecotic acid methyl ester;methyl 3-piperidinecarboxylate;Piperidin-carbonsaeure-3-methylester
3-哌啶甲酸甲酯化学式
CAS
50585-89-2
化学式
C7H13NO2
mdl
MFCD00797850
分子量
143.186
InChiKey
BCDBHIAXYFPJCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    193.8±33.0 °C(Predicted)
  • 密度:
    1.021±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:aff96da788cf6eee98274f9bd60bb523
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl piperidine-3-carboxylate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Methyl piperidine-3-carboxylate
CAS number: 50585-89-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H13NO2
Molecular weight: 143.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-哌啶甲酸甲酯甲醇 、 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 1.25h, 生成 1-甲基哌啶-3-甲醇
    参考文献:
    名称:
    [EN] CARBOXAMIDE INHIBITORS OF IRAK4 ACTIVITY
    [FR] CARBOXAMIDES UTILISÉS COMME INHIBITEURS DE L'ACTIVITÉ DE L'IRAK4
    摘要:
    本发明涉及式(I)的IRAK4的羧酰胺抑制剂,并提供包含这种抑制剂的组合物,以及用于治疗IRAK4介导或相关疾病或疾病的方法。
    公开号:
    WO2016144844A1
  • 作为产物:
    描述:
    3-哌啶甲酸乙酯氰化钠sodium carbonate 作用下, 以 二氯甲烷 为溶剂, 反应 51.0h, 生成 3-哌啶甲酸甲酯
    参考文献:
    名称:
    A convenient route to 1-benzyl 3-aminopyrrolidine and 3-aminopiperidine
    摘要:
    1-Benzyl 3-aminopyrrolidine 1 and 1-benzyl 3-aminopiperidine 2 were prepared rapidly mainly in aqueous conditions in 55 and 75%, yields, respectively, on a multi-gram scale starting from inexpensive and commercially available starting materials. The key step involved the Curtius rearrangement mediated by sodium nitrite and trifluoroacetic acid of the appropriate acylhydrazides. All the reactions (except LAH reductions) were performed in water. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(01)00985-6
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS<br/>[FR] NOUVEAUX INHIBITEURS À PETITES MOLÉCULES DE FACTEURS DE TRANSCRIPTION TEAD
    申请人:MASSACHUSETTS GEN HOSPITAL
    公开号:WO2020190774A1
    公开(公告)日:2020-09-24
    The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.
    本公开涉及化合物及其组合物和使用方法。这些化合物抑制TEAD转录因子的活性,并可用于治疗与TEAD转录因子活性相关的疾病,例如癌症和其他疾病。
  • Synthesis and Biological Activity of (S)-2-Amino-3(2,5-dihydro-5-oxo-4-isoxazolyl)propanoic Acid (TAN-950 A) Derivatives.
    作者:Norikazu TAMURA、Yoshihiro MATSUSHITA、Toshi IWAMA、Setsuo HARADA、Shoji KISHIMOTO、Katsumi ITOH
    DOI:10.1248/cpb.39.1199
    日期:——
    starting with methyl (S)- and (R)-N-Boc-pyroglutamate (8) via acylation at the C-4 position followed by isoxazolone formation with hydroxylamine and subsequent deprotection reactions. The lactam 16, prepared from (RS)-aminoadipic acid, and dimethyl esters 19 of (R)- and (S)-aspartic acid were converted to (RS)-3-methyl-homo-TAN-950 A (15i) and optically active nor-TAN-950 A derivatives 15j--o, respectively
    (S)-2-基-3-(2,5-二氢-5-氧代-4-异恶唑基)丙酸(TAN-950 A(1))是一种新型氨基酸抗生素,对谷酸受体具有高亲和力中枢神经系统。为了提高对谷酸受体的亲和力,研究了TAN-950 A衍生物6a-o,15a-o的构效关系。以(S)-和(R)-N-Boc-焦谷酸甲酯(8)为起始原料,通过C-4位的酰化反应合成旋光性TAN-950 A类似物15a-h,然后与羟胺形成异恶唑酮并随后脱保护反应。将由(RS)-己二酸和(R)-和(S)-天冬氨酸的二甲酯19制备的内酰胺16转化为(RS)-3-甲基-homo-TAN-950 A(15i)和利用相似的反应序列分别对光学活性的nor-TAN-950 A衍生物15j-o进行了研究。大多数TAN-950 A衍生物6a-o,15a-o对谷酸受体具有亲和力。3-烷基衍生物15b,d-g特别显示出对喹喹啉亚型受体的高亲和力,并对海马
  • Synthesis of C4-Aminated Indoles via a Catellani and Retro-Diels–Alder Strategy
    作者:Bo-Sheng Zhang、Yuke Li、Zhe Zhang、Yang An、Yu-Hua Wen、Xue-Ya Gou、Si-Qi Quan、Xin-Gang Wang、Yong-Min Liang
    DOI:10.1021/jacs.9b05009
    日期:2019.6.19
    N-benzoyloxyamines, and norbornadiene. The Catellani and retro-Diels-Alder strategy was used in this domino process. o-Iodoaniline, with electron-donating and sterically hindered protecting groups, made the reaction selective toward o-C-H amination. On the basis of density functional theory calculations, the intramolecular Buchwald coupling of this reaction underwent a dearomatization and a 1,3-palladium migration
    通过邻苯胺、N-苯甲酰氧基胺和降冰片二烯的三组分交叉偶联合成了高度官能化的 4-氨基吲哚。在这个多米诺骨牌过程中使用了 Catellani 和复古 Diels-Alder 策略。邻苯胺具有供电子和空间位阻保护基团,使反应对 oCH 胺化具有选择性。根据密度泛函理论计算,该反应的分子内 Buchwald 偶联经历了脱芳构化和 1,3-迁移过程。给出了保护基团控制化学选择性的原因。此外,实现了对 4-哌嗪吲哚和 GOT1 抑制剂的合成应用。
  • A General Catalyst Based on Cobalt Core–Shell Nanoparticles for the Hydrogenation of N‐Heteroarenes Including Pyridines
    作者:Kathiravan Murugesan、Vishwas G. Chandrashekhar、Carsten Kreyenschulte、Matthias Beller、Rajenahally V. Jagadeesh
    DOI:10.1002/anie.202004674
    日期:2020.9.28
    core–shell based nanoparticles prepared by template synthesis of cobalt‐pyromellitic acid on silica and subsequent pyrolysis. The optimal catalyst material allows for general and selective hydrogenation of pyridines, quinolines, and other heteroarenes including acridine, phenanthroline, naphthyridine, quinoxaline, imidazo[1,2‐a]pyridine, and indole under comparably mild reaction conditions. In addition
    在此,我们报道了通过二氧化硅均苯四酸的模板合成和随后的热解制备的特定二氧化硅负载的Co/Co 3 O 4核壳纳米粒子的合成。最佳的催化剂材料允许在相对温和的反应条件下对吡啶喹啉和其他杂芳烃(包括吖啶咯啉、啶、喹喔啉咪唑并[1,2-a]吡啶吲哚)进行全面和选择性氢化。此外,还展示了这些纳米颗粒的回收利用及其脱氢催化能力。
  • Reductive Alkylation of Amines with Carboxylic Ortho Esters
    作者:Renat Kadyrov、Konrad Moebus
    DOI:10.1002/adsc.202000510
    日期:2020.8.19
    carboxylic ortho esters could be used as an alkylating agent in the reductive alkylation of amines. A variety of amines, including amino acid esters, were alkylated affording mono‐alkylated products with high selectivity in practical to high yields using standard heterogeneous catalysts. By applying acyclic ortho esters alkylation was completed at room temperature.
    我们首次证明了羧酸原酸酯可以在胺的还原烷基化中用作烷基化剂。使用标准的多相催化剂,将多种胺(包括氨基酸酯)进行烷基化,从而以高产率实际可行地以高选择性生成单烷基化产物。通过施加无环原酸酯,在室温下完成烷基化。
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺